serena williams opens up about being on a glp 1 SerenaWilliams is opening her experience with the GLP-1 drug Zepbound. The recent public discourse around Williams's body—online commenters have noticed change in her physique and demanded to know how Serena Williams comeback has GLP-1

The medication can be an effective and safe therapeutic option for managing obesity (BMI 30 or more) and overweight (BMI 27 or more)

Aunque debemos seguir monitorizando futuros estudios para ver si existen riesgos a largo plazo, la evidencia hasta la fecha no respalda estas preocupaciones iniciales

sometimes a different approach or dose is needed

All case series and reports 151,152,153,154,155 reported better metabolic outcomes in patients with comorbid severe mental illness and diabetes and/or obesity who were concomitantly treated with antipsychotics and GLP-1RAs

Safety Profile: What We Learned About Side Effects Common Adverse Events The TRIUMPH-4 trial confirmed that retatrutide's side effect profile aligns with other incretin-based therapies, with gastrointestinal symptoms being the most common: Incidence of GI Side Effects (12mg dose): Nausea: 43% (vs 11% placebo) Diarrhea: 33% (vs 13% placebo) Vomiting: 21% (vs 0% placebo) Constipation: Elevated vs placebo Decreased appetite: Common Most gastrointestinal side effects were mild to moderate in severity and occurred primarily during the dose escalation phase